Sources Cited & Permissions

Sources Cited

Ganz ML, Smalarz AM, Krupski TL et al: Economic Costs of Overactive Bladder in the United States. Urology 2010: 75(3): 526-532.

Gormley, E. A., Lightner, D. J., Burgio, K. L., Chai, T. C., Clemens, J. C., Culkin, D. J., Das, A. K., Foster, Jr., H. E., Scarpero, H. M., Tessier, C. D., Vasavada, S. P.: Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) In Adults: AUA/SUFU Guideline. American Urological Association Education and Research, Inc. ©2012|Amended 2014, available online at:

Haylen BT, de Ridder D, Freeman RM et al: An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourology and Urodynamics 2010; 29: 4-20.

Martinson Melissa, MacDiarmid Scott, and Black Edward: Cost of Neuromodulation Therapies for Overactive Bladder: Percutaneous Tibial Nerve Stimulation Versus Sacral Nerve Stimulation. The Journal of Urology January 2013; 1879: 210-216.

National Association for Continence, available online at:

Volpi Eugenio: The Anatomy of the Autonomic Innervation of the Pelvic Organs: Some Considerations for the Pelvic Surgeon. The Trocar, online video journal of the International Society of Gynecological Endoscopy 06/03/2003, available online at:

U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health (CDRH): Information Sheet Guidance for IRBs, Clinical Investigators, and Sponsors: Significant Risk and Nonsignificant Risk Medical Devices, January 2006, available online at:


Images of FemPulse device copyright Ken Gutmaker Photography, used by permission.

Image of Alexandra Haessler, MD copyright Tom Seawell, used by permission.

Netter illustration #48848 from © Elsevier Inc., used under license.

Figure 1 of E. Volpi, A. Ferrero, P. Sismondi, Laparoscopic Identification of Pelvic Nerves in Patients with Deep Infiltrating Endometriosis, from: Surgical Endoscopy, 2004, volume 8, issue 7, pages 1109-1112, used under license with kind permission of Springer Science+Business Media.

Figure 4 from AUA/SUFU Overactive Bladder Guideline ©2012|Amended 2014, used by permission.


FemPulse and The Elegant Solution are trademarks of FemPulse LLC

Botox is a registered trademark of Allergan Inc.

Other companies, products, and journals referenced on this site are registered or unregistered trademarks of their respective owners.